Faculty, Staff and Student Publications

Language

English

Publication Date

10-1-2025

Journal

Oncogene

DOI

10.1038/s41388-025-03511-z

PMID

40753365

PMCID

PMC12436191

PubMedCentral® Posted Date

8-2-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Prostate cancer (PCa) bone metastasis (BM) poses a significant clinical challenge due to the heterogeneity of treatment responses and patient outcomes. In this study, we examined the role of Protein Kinase A (PKA) signaling in modulating the expression of osteopontin (SPP1/OPN), a protein associated with poor prognosis, within a subset of PCa BM patients. By integrating multi-omics results we identified a novel mechanism in which bone-derived type-I collagen (Col1a1) and fibronectin (Fn1) stimulate SPP1 expression in PCa cells through the activation of PKA signaling. This bone-induced regulation of SPP1 was confirmed both in vitro, using PCa-bone co-culture systems (PC3 or C42B/MC3T3 cell lines), and in vivo, using cell lines' engraftments and patient-derived xenografts (PDX) grown intrafemorally. Importantly, clinical data from longitudinal patient samples revealed that treatment with enzalutamide, an androgen receptor (AR) inhibitor, led to an increase in PKA signaling and corresponding SPP1 expression in a subpopulation of patients, highlighting the relevance of the PKA/SPP1 axis in disease progression under AR-targeted therapies. Overall, we underscored the critical role of the bone microenvironment in influencing PCa progression, pointing out to SPP1/OPN as a biomarker for identifying tumors with active PKA signaling, which could serve to manage resistance to AR-directed treatments.

Keywords

Osteopontin, Humans, Male, Animals, Bone Neoplasms, Prostatic Neoplasms, Cyclic AMP-Dependent Protein Kinases, Mice, Tumor Microenvironment, Disease Progression, Cell Line, Tumor, Signal Transduction, Benzamides, Nitriles, Collagen Type I, alpha 1 Chain, Gene Expression Regulation, Neoplastic, Collagen Type I, Phenylthiohydantoin, Bone and Bones, Xenograft Model Antitumor Assays, Bone metastases, Cancer microenvironment

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.